Personalised Diagnosis Could Transform Care for Rare Pregnancy Tumours – Wellbeing of Women
Wellbeing of Women shared a post on LinkedIn:
“The placenta is a temporary organ that helps the baby develop during a pregnancy. Some cells from the placenta remain in the patient’s womb following a pregnancy – usually this isn’t a problem, but in rare cases these cells can become cancerous.
Most of these cancers (which together are known as gestational trophoblastic neoplasia, or GTN for short) are curable. However, two rare types that represent just 5% of GTN cases account for almost all deaths.
At the moment, the only way to determine the survival of someone diagnosed with one of these rare GTNs is to genetically test the tumour and then test samples from each pregnancy. Funded by Wellbeing of Women, Dr Geoffrey Maher and collaborators at imperial college are researching how to personalise this testing to better support the individual needs of affected women – if successful, this research could mean that up to 85% of affected women are spared unnecessary surgeries, fertility loss and distress.
Read more about the research.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 14, 2026, 15:01Nitiz Murdia: 5,000 Indian Rupees and a 2-Room Fertility Clinic in 1988…
-
Oct 14, 2026, 14:58Devyanshi Dixit։ Can We Measure Ovarian Age?
-
Oct 14, 2026, 14:56Rohit Gutgutia: The IVF Price War, and Who Really Pays for It
-
Oct 14, 2026, 14:54Abdullah F. Edrees։ Marking an Important Milestone for IVF
-
Oct 14, 2026, 14:50Gregory Poulos: Pleased to Be Named President of Vios Fertility 2.0
-
Oct 13, 2026, 16:58Slavian Bumbu: A Low AMH Is Not an Infertility Diagnosis
-
Oct 13, 2026, 16:43Keshav Malhotra: No Embryologist or Laboratory Technique Can Guarantee Euploid Embryos
-
Oct 13, 2026, 16:37Tony Gordon: What Is the Most Successful Form of Fertility Treatment?
-
Oct 13, 2026, 16:29IVI RMA Global Introduces IVI Fertility